Quick Answer
BioCorRx Inc. reported Net Income of -$3.44 million for fiscal year 2025.
BioCorRx Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$3.44M | +32.6% |
| 2024 | -$5.11M | -35.4% |
| 2023 | -$3.77M | +13.9% |
| 2022 | -$4.38M | +16.0% |
| 2021 | -$5.21M | -48.6% |
| 2020 | -$3.51M | +42.0% |
| 2019 | -$6.05M | +8.1% |
| 2018 | -$6.58M | +77.8% |
| 2017 | -$29.71M | -403.1% |
| 2016 | -$5.90M | -26.5% |
| 2015 | -$4.67M | -49.2% |
| 2014 | -$3.13M | +18.5% |
| 2013 | -$3.84M | -333.3% |
| 2012 | -$885.8K | -116.6% |
| 2011 | -$409.0K | -164.5% |
| 2010 | -$154.6K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.92M | -28.9% | -55.5% |
| June 30, 2025 | -$1.23M | -1.3% | -46.6% |
| March 31, 2025 | -$841.4K | +32.0% | +43.4% |
| September 30, 2024 | -$1.49M | -71.5% | -22.2% |
| June 30, 2024 | -$1.22M | -31.8% | +1.6% |
| March 31, 2024 | -$1.24M | -22.4% | -42.6% |
| September 30, 2023 | -$867.3K | +8.8% | +6.1% |
| June 30, 2023 | -$923.5K | +29.9% | +8.6% |
- BioCorRx Inc. showed an increase of +32.6% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, BioCorRx Inc.’s net income has declined by 2125.3% (from -$154.6 thousand to -$3.44 million).
- The most recent figure is from BioCorRx Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: